Objectives: The human GSTTP1 gene is polymorphic with an A --> G transition
in exon 5 causing a replacement 105 Ile --> Val in the GSTP1 protein. The
two isoforms, encoded by the alleles GSTP1*A and GSTP1*B, respectively, sho
w different catalytic efficiencies towards some carcinogenic epoxides. In t
his study we have addressed the possible role of the Ile105Val GSTP1 polymo
rphism in lung cancer susceptibility.
Methods: The polymorphic site was genotyped by RFLP in a group of lung canc
er patients (n = 164) and in two control groups (healthy smokers, n = 132;
general population, n = 200). All patients and controls were Northwestern M
editerranean Caucasians of the same ethnic origin.
Results and Conclusions: The cancer patients showed frequencies of GSTP1*A/
A; GSTP1*A/B and GSTP1*B/B (50%, 38%, 11%, respectively) very similar to th
ose of both control groups (healthy smokers: 48%, 41%, 11%). After adjustin
g for age, sex and smoking status, no association was found between the GST
P1*B allele and lung cancer risk (OR: 1.18; 95% CI: 0.67-2.07). The Ile105v
al GSTP1 polymorphism was also analysed in combination with the GSTM1 and G
STT1 genes. The results showed that allelism at GSTP1 did not increase the
risk associated with the GSTM1 or GSTT1 deletions.